Portfolio (Quarterly)
Guide ↗
Knott David M Jr
· CIK 0001892770| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | AAPL | Apple Inc. | Technology | 2,494.0 | $678K | 0.31% | NEW | — | $271.86 | +13.7% |
| 42 | EOLS | Evolus, Inc. | Healthcare | 99,338.0 | $661K | 0.31% | NEW | — | $6.65 | -7.3% |
| 43 | NKTR | Nektar Therapeutics | Healthcare | 15,500.0 | $655K | 0.30% | NEW | — | $42.28 | +56.2% |
| 44 | IBM | International Business Machines | Technology | 2,142.0 | $634K | 0.29% | NEW | — | $296.21 | -15.7% |
| 45 | SRRK | Scholar Rock Holding Corporation | Healthcare | 13,913.0 | $613K | 0.28% | NEW | — | $44.05 | +15.0% |
| 46 | — | Pelthos Therapeutics, Inc. | — | 19,281.0 | $598K | 0.28% | NEW | — | $31.00 | — |
| 47 | CNQ | Canadian Natural Resources Limited | Energy | 16,800.0 | $569K | 0.26% | NEW | — | $33.85 | +38.9% |
| 48 | CNTB | Connect Biopharma Holdings Limited | Healthcare | 200,000.0 | $564K | 0.26% | NEW | — | $2.82 | -13.0% |
| 49 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 10,962.0 | $491K | 0.23% | NEW | — | $44.82 | +21.0% |
| 50 | AGIO | Agios Pharmaceutical, Inc. | Healthcare | 18,000.0 | $490K | 0.23% | NEW | — | $27.22 | +2.5% |
| 51 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 20,006.0 | $460K | 0.21% | NEW | — | $23.00 | +1.0% |
| 52 | — | Mersana Therapeutics, Inc. | — | 111,686.0 | $438K | 0.20% | NEW | — | $3.92 | — |
| 53 | KURA | Kura Oncology, Inc. | Healthcare | 39,209.0 | $407K | 0.19% | NEW | — | $10.39 | +6.2% |
| 54 | FATE | Fate Therapeutics, Inc. | Healthcare | 365,000.0 | $359K | 0.17% | NEW | — | $0.98 | +119.8% |
| 55 | — | Jasper Therapeutics, Inc. | — | 181,389.0 | $332K | 0.15% | NEW | — | $1.83 | — |
| 56 | IVVD | Invivyd, Inc. | Healthcare | 100,000.0 | $247K | 0.11% | NEW | — | $2.47 | -55.1% |
| 57 | AVGO | Broadcom, Inc. | Technology | 710.0 | $246K | 0.11% | NEW | — | $346.10 | +22.0% |
| 58 | KMB | Kimberly-Clark Corporation | Consumer Defensive | 2,400.0 | $242K | 0.11% | NEW | — | $100.89 | -1.8% |
| 59 | DAWN | Day One Biopharmaceuticals, Inc. | Healthcare | 25,884.0 | $241K | 0.11% | NEW | — | $9.32 | +131.0% |
| 60 | NVDA | Nvidia Corp | Technology | 1,280.0 | $239K | 0.11% | NEW | — | $186.50 | +14.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
53.7%
Financial Services
25.6%
Communication Services
18.0%
Technology
1.6%
Energy
0.4%
Consumer Defensive
0.3%
Basic Materials
0.2%
Consumer Cyclical
0.1%
Industrials
0.1%
Real Estate
0.1%